Plaintiffs Seek Consolidation of Another Mirena® Multidistrict Litigation (MDL 2559) Alleging Neurological Head Injuries
According to a recent report, ten plaintiffs seek to consolidate lawsuits in the Multidistrict Litigation In re: Mirena® IUD Levonorgestrel-Related Products Liability Litigation (MDL 2559) to address neurological head injuries, such as pseudotumor cerebri (PTC), as a result of the Mirena® intrauterine device’s alleged defect.
This new group of Mirena® lawsuits allege that the levonorgestrel hormone in the Mirena® contraceptive device causes increased pressure on the brain due to a build-up of cerebrospinal fluid. Patients report this pressure on the skull leads the body to react as if a brain tumor were present with the following symptoms: severe migraines, double vision, temporary blindness, ringing of the ears, and other adverse health problems.
This MDL follows another Mirena® Multidistrict Litigation (MDL 2434) against Bayer Corporation, the manufacturer of Mirena® IUD, that has already been centralized in the United States District Court for the Southern District of New York before The Honorable Cathy Seibel. In MDL 2434, plaintiffs’ pending lawsuits allege that Bayer failed to warn of other adverse health consequences, including allegations that the Mirena® IUD migrates from its original position in a woman’s body and causes serious injuries, such as uterine perforation, ectopic pregnancies, infertilities, and surgical removal of the device.
The choice of a lawyer is an important decision and should not be based solely on advertisements.